Pricing

Prometheus Biosciences Inc (RXDX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Mark C. Mckenna
Employees:
100
3050 SCIENCE PARK ROAD, SAN DIEGO, CA, 92121
(858) 422-4300

Are you looking for this stock instead?

PRA023, a humanized IgG1 monoclonal antibody (mAb) is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease. The company also develops PR600, an anti-tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available